Rani Therapeutics Holdings Inc. Class A share price logo

Rani Therapeutics Holdings Inc. Class A

NASDAQ: RANI

Small Cap

$0.78

+0.02

(+2.25%)

as on

Rani Therapeutics Holdings Inc. Class A Stock Performance

as on June 19, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $0.77
    $0.79
    downward going graph

    1.28%

    Downside

    1.28%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.39
    $3.87
    downward going graph

    50.38%

    Downside

    396.15%

    Upside

    downward going graph

Rani Therapeutics Holdings Inc. Class A share price movements today

Previous Close
$0.77
Open
$0.77
Volume
494.5K
Day's Low - High
$0.77 - $0.79
52 Week Low - High
$0.39 - $3.87

Rani Therapeutics Holdings Inc. Class A Historical Returns

1 Month Return
-11.53 %
3 Month Return
-31.97 %
1 Year Return
+ 54.02 %
3 Year Return
-82.3 %
5 Year Return
0 %

Rani Therapeutics Holdings Inc. Class A Stock Fundamentals & Key Indicators

Check Rani Therapeutics Holdings Inc. Class A market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$106.7M

EPS (TTM)

-0.1933

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-33.8M

Revenue (TTM)

3.2M

Profit Margin

0.00%

Return On Equity TTM

-239.96%

Rani Therapeutics Holdings Inc. Class A vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Rani Therapeutics Holdings Inc. Class A with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Rani Therapeutics Holdings Inc. Class A image
Rani Therapeutics Holdings Inc. Class A
BUY$106.7MNANA0.00%NA
Alnylam Pharmaceuticals Inc. image
Alnylam Pharmaceuticals Inc.
BUY$37.7B57.21%71.2112.55%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$116.5B140.42%27.2235.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$63.7B13.39%14.8529.65%0.58%

Stock Returns calculator for Rani Therapeutics Holdings Inc. Class A Stock including INR - Dollar returns

The Rani Therapeutics Holdings Inc. Class A stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Rani Therapeutics Holdings Inc. Class A investment value today

Current value as on today

₹1,66,596

Returns

₹66,596

(+66.6%)

Returns from Rani Therapeutics Holdings Inc. Class A Stock

₹52,941 (+52.94%)

Dollar Impact

₹13,655 (+13.65%)

Analyst Recommendation on Rani Therapeutics Holdings Inc. Class A Stock

Based on 13 analysts

BUY

92.31%

Buy

7.69%

Hold

0.00%

Sell

Based on 13 analysts, 92.31% of analysts recommend a 'BUY' rating for Rani Therapeutics Holdings Inc. Class A. Average target price of $7.5

Rani Therapeutics Holdings Inc. Class A Share Price Target

Get share price movements and forecasts by analysts on Rani Therapeutics Holdings Inc. Class A.

What analysts predicted

89.6%UPSIDE

Target Price

$7.5

Current Price

$0.78

Analyzed by

13 Analysts

Target

$7.50

Rani Therapeutics Holdings Inc. Class A target price $7.5, a slight upside of 89.6% compared to current price of $0.78. According to 13 analysts rating.

Indian Investors' Interest in Rani Therapeutics Holdings Inc. Class A Stock

Search interest for Rani Therapeutics Holdings Inc. Class A Stock has decreased by -45% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-45% versus previous 30 day period

Rani Therapeutics Holdings Inc. Class A Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
2
-
-
-
1
0
-
-
1
1
Gross Profit
2
0
0
0
1
0
0
0
1
1
Operating Income
-13
-14
-12
-11
-14
-12
-10
-7
-8
-8
EBITDA
-12
-13
-11
-11
-14
-11
-10
-6
-8
-7
Interest Expense
1
1
1
1
1
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-14
-14
-13
-12
-15
-12
-11
-7
-9
-8
Income Tax Expense
-6
-7
-6
-
-
-
-
-
-
-
Net Income
-7
-7
-6
-6
-8
-7
-6
-5
-10
-7
Net Profit Margin
-258.11%
0.00%
0.00%
0.00%
-870.33%
-4223.26%
0.00%
0.00%
-705.34%
-411.77%

Rani Therapeutics Holdings Inc. Class A Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
0
2
-
-
1
1
Gross Profit
0
0
2
-1
0
1
0
Operating Income
-27
-16
-51
-63
-66
-53
-38
EBITDA
-26
-15
-52
-61
-61
-50
-37
Interest Expense
0
0
0
1
5
5
2
Depreciation
0
0
0
0
0
1
0
Income Before Tax
-26
-16
-53
-63
-67
-30
-40
Income Tax Expense
0
0
0
0
-33
26
-
Net Income
-26
-16
-8
-30
-33
-30
-29
Net Profit Margin
-2716.75%
-3615.37%
-306.62%
0.00%
0.00%
-2920.04%
-1817.09%

Rani Therapeutics Holdings Inc. Class A Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-7
-6
-12
-15
-7
-6
-7
-9
-8
Operating Cash Flow
-9
-9
-8
-8
-8
-5
-5
0
-6
Investing Cash Flow
10
6
0
2
18
5
0
-30
-2
Financing Cash Flow
0
0
7
5
-3
0
-1
44
0
Change in Cash
1
-2
0
0
6
0
-6
14
-8

Rani Therapeutics Holdings Inc. Class A Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-16
-8
-63
-33
-56
-29
Operating Cash Flow
-14
-32
-46
-51
-35
-18
Investing Cash Flow
-1
0
-72
29
19
-7
Financing Cash Flow
72
77
29
0
13
40
Change in Cash
56
44
-89
-21
-2
14

Global Institutional Holdings in Rani Therapeutics Holdings Inc. Class A

Funds
Holdings
Vanguard Group Inc
5.12%
SymBiosis Capital Partners, LLC
3.67%
Nan Fung Group Holdings Ltd
0.49%
683 Capital Management LLC
0.49%
Insigneo Advisory Services LLC
0.1%
See all

Insights on Rani Therapeutics Holdings Inc. Class A

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, RANI has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Rani Therapeutics Holdings, Inc. Class A Common Stock has experienced a drawdown of -82.0%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 60.3%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, RANI stock has moved down by -26.9%

About Rani Therapeutics Holdings Inc. Class A

Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies. Its product pipeline includes RT-105, an anti-TNF-alpha antibody that is in preclinical studies to treat rheumatoid arthritis; RT-116 which is in discovery stage for the treatment of obesity; RT-117 for rare diseases; and RT-111, an ustekinumab biosimilar for the treatment of various inflammatory conditions. The have a collaboration agreement with ProGen Co., Ltd. for the o-development and commercialization of RT-114 to treat obesity; and Chugai Pharmaceutical Co., Ltd. to commercialize the Chugai Product combining Chugai's Compound, which is in development for hemophilia, and the RaniPill HC oral delivery device for use in humans. Rani Therapeutics Holdings, Inc. was founded in 2012 and is headquartered in San Jose, California.
OrganisationRani Therapeutics Holdings Inc. Class A
Headquarters2051 Ringwood Avenue, San Jose, CA, United States, 95131
IndustryBiotechnology
CEOMr. Talat Imran
E-voting on sharesClick here to vote

Key Management of Rani Therapeutics Holdings Inc. Class A

Name

Title

Mr. Mir A. Imran

Executive Chairman

Mr. Talat Imran

CEO & Director

Ms. Kate McKinley M.B.A.

Chief Business Officer

Ms. Bella Vazquez

Senior Vice President of People & Administrative Services

Mr. Jesper Hoeiland M.Sc.

Head of Strategy

Mr. Svai S. Sanford

Chief Financial Officer

Mr. Alireza Javadi Ph.D.

Chief Technical Officer

Dr. Mir Hashim

Chief Scientific Officer

Ms. Arvinder Dhalla

Vice President of Clinical Development

FAQs

What is Rani Therapeutics Holdings Inc. Class A share price today?

Rani Therapeutics Holdings Inc. Class A share price today is $0.78 as on at the close of the market. Rani Therapeutics Holdings Inc. Class A share today touched a day high of $0.79 and a low of $0.77.

What is the 52 week high and 52 week low for Rani Therapeutics Holdings Inc. Class A share?

Rani Therapeutics Holdings Inc. Class A share touched a 52 week high of $3.87 on and a 52 week low of $0.39 on . Rani Therapeutics Holdings Inc. Class A stock price today i.e. is closed at $0.78,which is 79.84% down from its 52 week high and 101.55% up from its 52 week low.

What is Rani Therapeutics Holdings Inc. Class A's market capitalisation today?

Rani Therapeutics Holdings Inc. Class A market capitalisation is $0.00T as on .

How to invest in Rani Therapeutics Holdings Inc. Class A Stock (RANI) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Rani Therapeutics Holdings Inc. Class A on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Rani Therapeutics Holdings Inc. Class A Shares that will get you 1.9231 shares as per Rani Therapeutics Holdings Inc. Class A share price of $0.78 per share as on June 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy Rani Therapeutics Holdings Inc. Class A Stock (RANI) from India?

Indian investors can start investing in Rani Therapeutics Holdings Inc. Class A (RANI) shares with as little as ₹94.31 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.10 in Rani Therapeutics Holdings Inc. Class A stock (as per the Rupee-Dollar exchange rate as on ). Based on Rani Therapeutics Holdings Inc. Class A share’s latest price of $0.78 as on June 19, 2026 at 8:45 am IST, you will get 12.8205 shares of Rani Therapeutics Holdings Inc. Class A. Learn more about fractional shares .